Vineet Laboratories Share Price Today (VINEETLAB)
TODAY IN ONE LINE
With a market cap of ₹74.9 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Vineet Laboratories flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.03x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 68.8% YoY
- ●Low Promoter HoldingPromoters hold only 6.0%
- ●Promoter SellingPromoter holding decreased by 13.37% QoQ
Latest Vineet Laboratories News
What changed recently?
Recent events, corporate actions, and announcements.
Vineet Laboratories Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Vineet Laboratories Limited, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Vineet Laboratories Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Vineet Laboratories Limited — derived from the live tape, not yesterday's close.
Vineet Laboratories Limited last traded at ₹38.55 with an intraday range of ₹36.51–₹39 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹38.55| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 44.51 | +5.96 | +15.46% |
| R3 | 42.02 | +3.47 | +9.00% |
| R2 | 40.51 | +1.96 | +5.08% |
| R1 | 39.53 | +0.98 | +2.54% |
| PIVOT | 38.02 | -0.53 | -1.37% |
| CURRENT | 38.55 | — | — |
| S1 | 37.04 | -1.51 | -3.92% |
| S2 | 35.53 | -3.02 | -7.83% |
| S3 | 34.55 | -4.00 | -10.38% |
| S4 | 32.06 | -6.49 | -16.84% |
VINEETLAB is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹–₹
Trading Inside opening range
Vineet Laboratories Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Vineet Laboratories Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Vineet Laboratories Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹74.9 Cr. and reported EPS of ₹-20.47.
Vineet Laboratories segment analysis : revenue and profit mix.
Disclosed business segments at Vineet Laboratories with their share of revenue and profit, switchable between consolidated and standalone reporting.
Vineet Laboratories discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Vineet Laboratories Limited.
Our AI distills the core fundamental drivers supporting Vineet Laboratories Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Vineet Laboratories Limited's investment case rests on 4 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Pharmaceutical sector offers growth from increasing healthcare demand and advancements.
Diversification into new products or markets could capture emerging needs.
Strategic overhaul, including cost optimization, could unlock future growth potential.
Small market cap (424.35 Cr) makes it potential acquisition target.
Key Risks.
Severe unprofitability with ROE -89.50% and ROCE -28.00%.
Quarterly sales plummeted -68.80%, indicating significant revenue contraction.
High debt-to-equity ratio of 2.74 poses substantial financial risk.
Promoter holding declined from 38.66% to 15.9%, signaling low confidence.
Consistent negative EPS -20.47 reflects inability to generate positive earnings.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 3.23. Balance sheet risk re-prices growth multiples fast.
Vineet Laboratories Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Vineet Laboratories Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Vineet Laboratories Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Vineet Laboratories Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Vineet Laboratories Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Vineet Laboratories Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Vineet Laboratories Limited stood at 61.9% of traded volume, against a 20-day average of 57.8%.
Vineet Laboratories announcements: results, concalls, ratings, M&A.
Filings Vineet Laboratories sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Vineet Laboratories files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 86 documents below.
Cessation
Vineet Laboratories Limited has informed the Exchange regarding Cessation of Mr. Gaddam Venkata Ramana (DIN: 00031873) as Managing Director of the…
Change in Director(s)
Vineet Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.
General Updates
Vineet Laboratories Limited has informed the Exchange about General Updates
Disclosure under SEBI Takeover Regulations
A SRINIVASA RAJU has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial…
Vineet Laboratories dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Vineet Laboratories has declared, sequenced by announce and record date.
Vineet Laboratories corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Vineet Laboratories insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Vineet Laboratories as reported to SEBI — buying and selling signals from the people who know the business best.
Vineet Laboratories insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| VENKATA RAMAGADDAM | Insider | 26 May 2025 | sell | −70.0 K | ₹22.47 L | ₹32.10 |
| Alluri Srinivasa Raju | Insider | 16 May 2025 | sell | −25.0 K | ₹8.08 L | ₹32.32 |
| Alluri Srinivasa Raju | Insider | 16 May 2025 | sell | −25.0 K | ₹8.08 L | ₹32.30 |
| Alluri Srinivasa Raju | Insider | 15 May 2025 | sell | −25.0 K | ₹7.66 L | ₹30.62 |
| Alluri Srinivasa Raju | Insider | 15 May 2025 | sell | −25.0 K | ₹7.64 L | ₹30.55 |
About Vineet Laboratories Limited: business, sector, key facts.
What Vineet Laboratories Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Vineet Laboratories Limited operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: VINEETLAB, BSE: 543298.
Vineet Laboratories Limited is an Indian company specializing in the research, development, manufacturing, and sales of active pharmaceutical ingredients (APIs) and fine chemicals. Their primary focus is on supplying crucial components for the pharmaceutical industry, contributing to the production of various medications.
A significant portion of Vineet Labs' business involves the production of intermediates for several key APIs. These intermediates are essential building blocks used in the synthesis of finished pharmaceutical products. Specific examples of APIs for which they supply intermediates include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. The company's ability to reliably produce these intermediates is vital to the supply chains of pharmaceutical manufacturers.
Beyond APIs, Vineet Laboratories also offers a diverse range of fine chemicals and reagents. These chemicals serve a variety of purposes in research and manufacturing settings, extending their reach beyond just pharmaceutical applications. The list of fine chemicals they provide is extensive and includes compounds such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, and various other specialized reagents. This diversification broadens their customer base and enhances their market position.
Established in 2007 and headquartered in Hyderabad, India, Vineet Laboratories has built its foundation on providing high-quality chemical products to both domestic and potentially international markets. Their success is likely linked to their expertise in chemical synthesis, quality control, and meeting the stringent demands of the pharmaceutical and research industries. The company’s commitment to research and development likely allows them to adapt to evolving market needs and introduce new products.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share PricePeer
- Aarti Drugs (AARTIDRUGS) Share PricePeer
- Aarti Pharmalabs (AARTIPHARM) Share PricePeer
- Ajanta Pharma (AJANTPHARM) Share PricePeer
- Akums Drugs and Pharmaceuticals (AKUMS) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Vineet Laboratories Limited (VINEETLAB).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Vineet Laboratories Limited (VINEETLAB)?
The current share price of Vineet Laboratories Limited (VINEETLAB) is ₹38.55. Today, the stock has gained by ₹2.11 (5.79%), trading in a range of ₹36.51 to ₹39. The stock opened at ₹37.36 with a trading volume of 2,01,788 shares.
02What is the 52-week high and low price of Vineet Laboratories Limited stock?
The 52-week high price of Vineet Laboratories Limited (VINEETLAB) is ₹49.99, while the 52-week low is ₹27.96. Currently trading at ₹38.55, the stock is 48.1% away from its 52-week low and 22.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of Vineet Laboratories Limited and when is the next dividend?
Vineet Laboratories Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹38.55, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is Vineet Laboratories Limited stock performing today in the market?
Vineet Laboratories Limited stock opened at ₹37.36 and is currently trading at ₹38.55, showing a gain of ₹2.11 (5.79%). The intraday high is ₹39 and low is ₹36.51. The trading volume stands at 2,01,788 shares, indicating moderate market participation today.
05What is the market capitalization of Vineet Laboratories Limited?
Vineet Laboratories Limited has a market capitalization of ₹74.9 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹38.55) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06Which sector and industry does Vineet Laboratories Limited belong to?
Vineet Laboratories Limited operates in the Healthcare sector and belongs to the Pharmaceuticals industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
07What is the debt-to-equity ratio of Vineet Laboratories Limited?
Vineet Laboratories Limited has a debt-to-equity ratio of 2.73, which measures the company's financial leverage by comparing total debt to shareholders' equity. A ratio above 2 indicates high leverage and potentially higher financial risk. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
08What is the sales and profit growth of Vineet Laboratories Limited?
Vineet Laboratories Limited has reported a sales growth of 11.05% and profit growth of 59.20%. Moderate growth suggests steady business performance. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
The data, ratios and commentary about Vineet Laboratories Limited (VINEETLAB) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.